200 related articles for article (PubMed ID: 36675972)
1. RNA Foci Formation in a Retinal Glial Model for Spinocerebellar Ataxia Type 7.
Suárez-Sánchez R; Ávila-Avilés RD; Hernández-Hernández JM; Sánchez-Celis D; Azotla-Vilchis CN; Gómez-Macías ER; Leyva-García N; Ortega A; Magaña JJ; Cisneros B; Hernández-Hernández O
Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36675972
[TBL] [Abstract][Full Text] [Related]
2. Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Niewiadomska-Cimicka A; Trottier Y
Neurotherapeutics; 2019 Oct; 16(4):1074-1096. PubMed ID: 31432449
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
4. Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
Furrer SA; Waldherr SM; Mohanachandran MS; Baughn TD; Nguyen KT; Sopher BL; Damian VA; Garden GA; La Spada AR
Hum Mol Genet; 2013 Mar; 22(5):890-903. PubMed ID: 23197655
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
[TBL] [Abstract][Full Text] [Related]
6. Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.
Chen YC; Gatchel JR; Lewis RW; Mao CA; Grant PA; Zoghbi HY; Dent SY
Hum Mol Genet; 2012 Jan; 21(2):394-405. PubMed ID: 22002997
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.
Karam A; Trottier Y
Adv Exp Med Biol; 2018; 1049():197-218. PubMed ID: 29427104
[TBL] [Abstract][Full Text] [Related]
8. Altered p53 and NOX1 activity cause bioenergetic defects in a SCA7 polyglutamine disease model.
Ajayi A; Yu X; Wahlo-Svedin C; Tsirigotaki G; Karlström V; Ström AL
Biochim Biophys Acta; 2015; 1847(4-5):418-428. PubMed ID: 25647692
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
[TBL] [Abstract][Full Text] [Related]
10. Pulling complexes out of complex diseases: Spinocerebellar Ataxia 7.
Mohan RD; Abmayr SM; Workman JL
Rare Dis; 2014; 2():e28859. PubMed ID: 25054097
[TBL] [Abstract][Full Text] [Related]
11. Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.
Fiszer A; Wroblewska JP; Nowak BM; Krzyzosiak WJ
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27999335
[TBL] [Abstract][Full Text] [Related]
12. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
13. SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.
Niewiadomska-Cimicka A; Doussau F; Perot JB; Roux MJ; Keime C; Hache A; Piguet F; Novati A; Weber C; Yalcin B; Meziane H; Champy MF; Grandgirard E; Karam A; Messaddeq N; Eisenmann A; Brouillet E; Nguyen HHP; Flament J; Isope P; Trottier Y
J Neurosci; 2021 Jun; 41(22):4910-4936. PubMed ID: 33888607
[TBL] [Abstract][Full Text] [Related]
14. Polyglutamine expanded Ataxin-7 induces DNA damage and alters FUS localization and function.
Niss F; Zaidi W; Hallberg E; Ström AL
Mol Cell Neurosci; 2021 Jan; 110():103584. PubMed ID: 33338633
[TBL] [Abstract][Full Text] [Related]
15. Progressive degeneration in a new
Sujkowski AL; Ranxhi B; Prifti MV; Alam N; Todi SV; Tsou WL
Res Sq; 2023 Nov; ():. PubMed ID: 38045332
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins.
Alves S; Marais T; Biferi MG; Furling D; Marinello M; El Hachimi K; Cartier N; Ruberg M; Stevanin G; Brice A; Barkats M; Sittler A
Mol Neurodegener; 2016 Jul; 11(1):58. PubMed ID: 27465358
[TBL] [Abstract][Full Text] [Related]
17. Progressive degeneration in a new
Sujkowski AL; Ranxhi B; Prifti MV; Alam N; Todi SV; Tsou WL
bioRxiv; 2023 Nov; ():. PubMed ID: 37986914
[TBL] [Abstract][Full Text] [Related]
18. The Molecular Basis of Spinocerebellar Ataxia Type 7.
Goswami R; Bello AI; Bean J; Costanzo KM; Omer B; Cornelio-Parra D; Odah R; Ahluwalia A; Allan SK; Nguyen N; Shores T; Aziz NA; Mohan RD
Front Neurosci; 2022; 16():818757. PubMed ID: 35401096
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
[TBL] [Abstract][Full Text] [Related]
20. Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice.
Chort A; Alves S; Marinello M; Dufresnois B; Dornbierer JG; Tesson C; Latouche M; Baker DP; Barkats M; El Hachimi KH; Ruberg M; Janer A; Stevanin G; Brice A; Sittler A
Brain; 2013 Jun; 136(Pt 6):1732-45. PubMed ID: 23518714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
